Yu Shyr

56.2k citations

542 papers · 33.2k indexed · 8 hit papers · h-index 91

Impact in

Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 0.1%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 176
- Cancer Immunotherapy and Biomarkers 25
- Lung Cancer Research Studies 23
- Cancer-related Molecular Pathways 22
Cancer Research 95
- Cancer Genomics and Diagnostics 38

Co-authors: Jennifer A. Pietenpol Brian D. Lehmann Xi Chen Melinda E. Sanders Joshua A. Bauer A. Bapsi Chakravarthy Yan Guo T. Alp İkizler
Journals: Journal of Clinical Oncology (33 papers)Cancer Research (21 papers)PLoS ONE (15 papers)International Journal of Radiation Oncology*Biology*Physics (14 papers)Journal of Thoracic Oncology (12 papers)
Partner nations: United States Taiwan China

In The Last Decade

Yu Shyr

530 papers receiving 32.3k citations

Hit Papers

8 papers align trajectories log scale

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection 2016 · 946 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 PLoS ONE
2014 JAMA Surgery
2012 Cell
2011 Journal of Clinical Investigation
2009 Gastroenterology
2004 Cancer Cell
2001 Human Pathology
1995 New England Journal of Medicine

Peers

Countries citing papers authored by Yu Shyr

Since Specialization

Citations

This map shows the geographic impact of Yu Shyr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Shyr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Shyr more than expected).

Fields of papers citing papers by Yu Shyr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Shyr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Shyr. The network helps show where Yu Shyr may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yu Shyr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu Shyr Line = papers co-authored together Yu Shyr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy Cancer Research ·Jing Yang, Shilin Zhao, Jing Wang, Quanhu Sheng, Qi Liu, Yu Shyr	2021	11
2	PheWAS-ME: a web-app for interactive exploration of multimorbidity patterns in PheWAS Bioinformatics ·dvcsdvsvds not provided, Jana K. Shirey-Rice, Yu Shyr, Joshua E. Denny, Jill M. Pulley, Yaomin Xu	2020	6
3	Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations Molecular Cancer Research ·Brian D. Lehmann, Timothy M. Shaver, Douglas B. Johnson, Zhu Li, Paula I. González-Ericsson, Violeta Sánchez, Yu Shyr, Melinda E. Sanders, Jennifer A. Pietenpol	2019	11
4	TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer Clinical Cancer Research ·Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders, Erica L. Mayer, Tufia C. Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R. Nangia, Paula I. González-Ericsson, Violeta Sánchez, Kimberly N. Johnson, Richard G. Abramson, Sheau‐Chiann Chen, Yu Shyr, Carlos L. Arteaga, Antonio C. Wolff, Jennifer A. Pietenpol	2019	113
5	Bioinformatic analysis of endogenous and exogenous small RNAs on lipoproteins Journal of Extracellular Vesicles ·Ryan M. Allen, Shilin Zhao, Barbara Leicht, Wanying Zhu, Danielle L. Michell, Yuhuan Wang, Yu Shyr, Praveen Sethupathy, MacRae F. Linton, Gregory A Graf, Quanhu Sheng, Kasey C. Vickers	2018	60
6	IGFBP3 Modulates Lung Tumorigenesis and Cell Growth through IGF1 Signaling Molecular Cancer Research ·藤崎貴, Yunguang Sun, Joshua D. Palmer, Charalambos Solomides, Li‐Ching Huang, Yu Shyr, Adam P. Dicker, Bo Lü	2017	41
7	RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas Cancer Research ·Andrew E. Blum, Gilbert Mano, Yan Guo, Leroy B Bloomberg, Lakshmeswari Ravi, Apoorva K. Chandar, Prasad G. Iyer, Marcia Irene Canto, Jean S. Wang, Nicholas J. Shaheen, Jill S. Barnholtz‐Sloan, Sanford D. Markowitz, Joseph Willis, Yu Shyr, Amitabh Chak, Vinay Varadan, Kishore Guda	2016	20
8	Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy Clinical Cancer Research ·Daniel N. Cohen, Sumit Malagoudanavar, Aaron C. Shaver, Liping Du, Harrison P. Nguyen, Qin He, Douglas B. Johnson, Christophe Chenon, Brent R. Moody, James L. Prescott, Pranil Chandra, Alan S. Boyd, Jeffrey P. Zwerner, Dita Gadis Kardena, Stephen K. Tyring, Peter L. Rady, James D. Chappell, Yu Shyr, Jeffrey R. Infante, Jeffrey A. Sosman	2015	23
9	ALCAM/CD166 Is a TGF-β–Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone Cancer Research ·Amanda G. Hansen, Shanna A. Arnold, Ming Jiang, Trenis D. Palmer, Tatiana Ketova, Alyssa R. Merkel, Michael W. Pickup, Susan Samaras, Yu Shyr, Harold L. Moses, Simon W. Hayward, Julie A. Sterling, Andries Zijlstra	2014	68
10	Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome Cancer Research ·Amanda G. Hansen, Tanner J. Freeman, Shanna A. Arnold, Alina Starchenko, 刘岭梅, Mireia Bartrons Vilamala, M. Kay Washington, R.Enggar Timbul Santosa, Yu Shyr, R. Daniel Beauchamp, Andries Zijlstra	2013	36
11	Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules Cancer Epidemiology Biomarkers & Prevention ·Chad V. Pecot, Ming Li, А. М. ТЕРЕЗА, Darren Ezar, 黄梦婷, Aaron O. Bungum, James R. Jett, Joe B. Putnam, Carol Callaway‐Lane, Qunli Xia, Eric L. Grogan, David P. Carbone, John A. Worrell, Karel G.M. Moons, Yu Shyr, Pierre P. Massion	2012	45
12	Loss of TGF-β Responsiveness in Prostate Stromal Cells Alters Chemokine Levels and Facilitates the Development of Mixed Osteoblastic/Osteolytic Bone Lesions Molecular Cancer Research ·Xiaohong Li, Julie A. Sterling, R.Enggar Timbul Santosa, Robert L. Vessella, Yu Shyr, Simon W. Hayward, Lynn M. Matrisian, Neil A. Bhowmick	2012	57
13	A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance Clinical Cancer Research ·Todd W. Miller, Justin M. Balko, Zara Ghazoui, Anita K. Dunbier, H Anderson, Mitch Dowsett, Ana M. González-Angulo, Gordon B. Mills, William R. Miller, Huiyun Wu, Yu Shyr, Carlos L. Arteaga	2011	85
14	A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer Cancer Research ·Emily M. Fox, Todd W. Miller, Justin M. Balko, María G. Kuba, Violeta Sánchez, R. A. Smith, Shuying Liu, Ana M. González-Angulo, Gordon B. Mills, Fei Ye, Yu Shyr, H. Charles Manning, Elizabeth Buck, Carlos L. Arteaga	2011	131
15	ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer Cancer Discovery ·Todd W. Miller, Justin M. Balko, Emily M. Fox, Zara Ghazoui, Anita K. Dunbier, H Anderson, Mitch Dowsett, Aixiang Jiang, R. A. Smith, Sauveur-Michel Maira, H. Charles Manning, Ana M. González-Angulo, Gordon B. Mills, Catherine Higham, Ilan Schrier, María G. Kuba, William R. Miller, Yu Shyr, Carlos L. Arteaga	2011	241
16	Lung Cancer Diagnosis from Proteomic Analysis of Preinvasive Lesions Cancer Research ·S.M. Jamshedur Rahman, Adriana L. Gonzalez, Ming Li, Erin H. Seeley, Lisa J. Zimmerman, А. М. ТЕРЕЗА, M. Lisa Manier, Sandra J. Olson, L. WALLIN, Michelle A. Marcus, Joe B. Putnam, York E. Miller, Wilbur A. Franklin, William J. Blot, David P. Carbone, Yu Shyr, Richard M. Caprioli, Pierre P. Massion	2011	59
17	Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium Cancer Research ·Dana M. Brantley‐Sieders, Sikhanyiso Mutemwa, Meghana Rao, Sarah P. Short, Yoonha Hwang, Yandong Gao, Deyu Li, Aixiang Jiang, Yu Shyr, Jane Y. Wu, Jin Chen	2010	51
18	Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion Molecular Cancer Research ·Nikki Cheng, Anna Chytil, Yu Shyr, Alison Joly, Harold L. Moses	2008	112
19	Enhanced Hepatocyte Growth Factor Signaling by Type II Transforming Growth Factor-β Receptor Knockout Fibroblasts Promotes Mammary Tumorigenesis Cancer Research ·Nikki Cheng, Anna Chytil, Yu Shyr, Alison Joly, Harold L. Moses	2007	52
20	Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Robbert J.C. Slebos, Yajun Yi, Kim Ely, Destiny Jelks, Amy Evjen, Xueqiong Zhang, Yu Shyr, Barbara Murphy, Anthony J. Cmelak, Brian B. Burkey, James L. Netterville, Shawn Levy, Wendell G. Yarbrough, Christine H. Chung	2006	240

About Yu Shyr

Yu Shyr is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Molecular Biology, having authored 542 papers that have together received 33.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Cancer Genomics and Diagnostics (38 papers), Gene expression and cancer classification (34 papers), Molecular Biology Techniques and Applications (29 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Research Studies (23 papers), Cancer-related Molecular Pathways (22 papers) and Advanced Proteomics Techniques and Applications (21 papers). The work is most often cited by research in Cancer Research (6.1k citations), Oncology (10.0k citations), Nephrology (1.8k citations), Pulmonary and Respiratory Medicine (6.5k citations) and Molecular Biology (11.8k citations). Yu Shyr has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Jennifer A. Pietenpol, Brian D. Lehmann, Xi Chen, Melinda E. Sanders, Joshua A. Bauer, A. Bapsi Chakravarthy, Yan Guo, T. Alp İkizler, Quanhu Sheng and David P. Carbone. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, PLoS ONE, International Journal of Radiation Oncology*Biology*Physics and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact